NEW STEP BY STEP MAP FOR FLüSSIGES AMPHETAMIN KAUFEN

They system to finish this next stage III review by the tip of this yr. As soon as the phase III is full, MAPS will submit an application for FDA approval for MDMA therapy. They foresee FDA approval to come in late 2023. The moment it's authorised, the DEA will have 3 months to re-program or de-timetable MDMA from its current Agenda-1 position. MAP